Diffusion tensor imaging in Alzheimer's disease and dementia with Lewy bodies

Michael J Firbank1, Andrew M Blamire, Andrew Teodorczuk

  • 1Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK. m.j.firbank@ncl.ac.uk

Psychiatry Research
|September 30, 2011
PubMed

Insights

This study reveals distinct white matter changes in Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) using MRI. DLB showed reduced fractional anisotropy linked to motor function, while AD had increased diffusivity in the temporal lobe.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • White matter alterations are implicated in Alzheimer's disease (AD) but less studied in dementia with Lewy bodies (DLB).
  • Diffusion imaging provides insights into white matter microstructure.

Purpose of the Study:

  • To investigate and compare white matter changes in AD and DLB using diffusion-weighted MRI.
  • To correlate white matter findings with clinical symptoms and hippocampal integrity.

Main Methods:

  • Diffusion-weighted magnetic resonance imaging (MRI) and high-resolution 3T MRI of the medial temporal lobe.
  • Analysis included 16 subjects with AD, 16 with DLB, and 16 healthy controls.
  • Statistical Parametric Mapping (SPM) analysis was employed.

Main Results:

  • Increased mean diffusivity in the temporal lobe of AD patients.
  • Reduced fractional anisotropy (FA) in the right postcentral gyrus in DLB, correlating with UPDRS motor scores.
  • Reduced FA in the corpus callosum, fornix, and stria terminalis correlated with visual hippocampal ratings.

Conclusions:

  • Hippocampal changes in AD are associated with white matter alterations in its output pathways.
  • Motor function deficits in DLB are linked to white matter changes beneath the somatosensory cortex.
  • Diffusion imaging can differentiate white matter pathologies in AD and DLB.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...